☰

Michael L. Penn, Ph.D. - Publications

Affiliations: 
2000 University of California, San Francisco, San Francisco, CA 
Area:
Microbiology Biology, Immunology
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2001 Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, Greene WC, Goldsmith MA. HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. The Journal of Experimental Medicine. 194: 1407-19. PMID 11714748 DOI: 10.1084/Jem.194.10.1407  0.759
2001 Eckstein DA, Penn ML, Korin YD, Scripture-Adams DD, Zack JA, Kreisberg JF, Roederer M, Sherman MP, Chin PS, Goldsmith MA. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity. 15: 671-82. PMID 11672548 DOI: 10.1016/S1074-7613(01)00217-5  0.766
2001 Penn ML, Myers M, Eckstein DA, Liegler TJ, Hayden M, Mammano F, Clavel F, Deeks SG, Grant RM, Goldsmith MA. Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues. Aids Research and Human Retroviruses. 17: 517-23. PMID 11350665 DOI: 10.1089/08892220151126580  0.765
2000 Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. Journal of Virology. 74: 9594-600. PMID 11000231 DOI: 10.1128/Jvi.74.20.9594-9600.2000  0.716
2000 Grivel JC, Penn ML, Eckstein DA, Schramm B, Speck RF, Abbey NW, Herndier B, Margolis L, Goldsmith MA. Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. Journal of Virology. 74: 5347-51. PMID 10799612 DOI: 10.1128/Jvi.74.11.5347-5351.2000  0.754
2000 Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA. Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. Journal of Virology. 74: 184-92. PMID 10590105 DOI: 10.1128/Jvi.74.1.184-192.2000  0.758
1999 Speck RF, Esser U, Penn ML, Eckstein DA, Pulliam L, Chan SY, Goldsmith MA. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Current Biology : Cb. 9: 547-50. PMID 10339429 DOI: 10.1016/S0960-9822(99)80241-3  0.754
1999 Penn ML, Grivel JC, Schramm B, Goldsmith MA, Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proceedings of the National Academy of Sciences of the United States of America. 96: 663-8. PMID 9892690 DOI: 10.1073/Pnas.96.2.663  0.816
1998 Speck RF, Penn ML, Wimmer J, Esser U, Hague BF, Kindt TJ, Atchison RE, Goldsmith MA. Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. Journal of Virology. 72: 5728-34. PMID 9621031 DOI: 10.1128/Jvi.72.7.5728-5734.1998  0.808
Show low-probability matches.